Recombinant C1-Inhibitor: Effects on Coagulation and Fibrinolysis in Patients with Hereditary Angioedema

ISSN： 1173-8804

Source： BioDrugs, Vol.26, Iss.1, 2012-02, pp. : 43-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Human C1 Inhibitor (Conestat Alfa): In the Treatment of Angioedema Attacks in Hereditary Angioedema

By Plosker Greg L.

BioDrugs, Vol. 26, Iss. 5, 2012-10 ,pp. : 315-323

Adis International

Access to resources Recommend Favorite

Nanofiltered Human C1 Inhibitor Concentrate (Cinryze®): In Hereditary Angioedema

By Lyseng-Williamson Katherine A.

BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. : 317-327

Adis International

Access to resources Recommend Favorite

Immunogenicity Assessment of Recombinant Human C1-Inhibitor: An Integrated Analysis of Clinical Studies

By Hack C. Erik

BioDrugs, Vol. 26, Iss. 5, 2012-10 ,pp. : 303-313

Adis International

Access to resources Recommend Favorite

Ecallantide in Acute Hereditary Angioedema†: Profile Report

By Garnock-Jones Karly P.

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 51-52

Adis International

Access to resources Recommend Favorite

Potentially lethal ACE‐inhibitor‐induced angioedema in a child

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 427-430

John Wiley & Sons Inc

Access to resources Recommend Favorite